Share Twitter LinkedIn Facebook Email Adriana Rossi, M.D. Associate Clinical Director Myeloma Center Weill Cornell Medicine Discusses The Role Of Ixazomib In Front Line Therapy at Lymphoma & Myeloma on October 18, 2018.
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read